- Might Amazon do to PBMs what it’s done to retailers? The ecommerce goliath is reportedly making hires with a view toward getting into the pharmacy game – a move that could shake up the payer pecking order and give pharmas a formidable negotiating partner on pricing. Some experts think that despite Amazon’s brand value, reach and scale, it will have trouble displacing incumbents like ExpressScripts and CVS. Others think Amazon could bring just the jolt of pricing transparency the PBM market needs. In any case, it’s another side effect of high-deductible plans pushing more of the cost burden onto consumers, and few companies understand how to engage consumers better than Amazon.
- The WannaCry ransomware attack that shut down the IT systems of many hospitals worldwide, including much of the NHS, is a sign of the vulnerability of hospitals and health systems to disruption by hackers – and calls into question any notion of medical privacy.
- For all the furor over pricing in the US, Edelman’s Trust Barometer study found that perceptions of the industry have improved over the past year – well, to ‘Meh,’ from ‘Better than Ebola,” more or less. Fifty-one percent of those surveyed said they trust the industry, though an overwhelming number say pharma puts profits ahead of patient health.
- Why the improvement? Edelman’s Kym White cites innovation as a major factor. Here’s one ripped-from-the-headlines example: the World Health Organization is weighing deploying an experimental Ebola vaccine developed by Merck in the Democratic Republic of Congo, where an outbreak of the hemorrhagic fever has flared in recent days.
- Verily hired former FDA Commissioner Robert Califf to serve in an as-yet undefined role. It’s a win for the Google life sciences spinoff, which has suffered a brain drain in recent months, amid reports of internal strife. Califf, meanwhile, had some interesting things to say about the need for the industry to define ethical off-label promotion in the wake of legal decisions circumscribing the FDA’s role in policing it.
- Here’s a look at how one AI company (that is not Watson) is using deep learning to aid in lung cancer diagnosis in China. For all the justified skepticism of AI, David Shaywitz says the technologies appear at last to be poised to live up to the hype, and that HCPs will need to make nice with the likes of Watson.
- A small study looking at the use of texts to promote adherence found very high engagement for a fully-automated, two-way text messaging adherence service from Epharmix which went beyond rote reminders to ask why patients had missed a dose.
- Digital ID consortia that give physicians easy access to pharma sites in exchange for more granular tracking are gaining steam – and the concept is being tested with renewed energy by less-regulated industries, as well.
- Researchers using wearable biosensors were able to predict with 79%-80% accuracy whether patients with autism were going to “aggress to someone else or to themselves” within the next minute, based on movement data.
Most Recent Articles
Pharma innovation: It's a thing (your mileage may vary)
Yes, there is innovation happening in pharma digital marketing. It's just unevenly distributed.
The three essential 'E's of the U.S. patient experience
The three areas of unmet need where pharma can play in bettering the U.S. patient experience: Empathy, empowerment, and expense.
Ready for voice search and virtual assistants? Physicians are
The way doctors search for information is evolving to include voice search through virtual assistance. Here's what multichannel pharma marketers need to know as HCPs move from search to Siri.
Digital health news update: AI plays from Babylon, Samsung and AARP
DRG Digital's occasional roundup of news of note from the world's of healthcare, technology, digital health and pharma
Get personal to reach Australian oncologists
Study data shows that Australian oncologists want greater customization of digital information from pharma.
WhatsApp could prove a powerful patient engagement tool for pharma
WhatsApp's enormous user base in many global markets means it could serve to connect pharma with patients -- provided that data security standards can be met
The New Goal of Pharma DTC Marketing (video)
DRG Digital | Manhattan Research chief strategist Jeff Greene and Principal Analyst give their take on the DTC National 2018
Which pharmas do U.S. physicians count as trusted partners?
An illustration of which pharmas U.S. physicians trust most and how that relates to provision of quality, up-to-date online information.
Voice search is big with doctors in China, Taking the Pulse data reveal
Physicians' use of voice assistants in China is on par with that of their Western counterparts, according to data from DRG Digital's Taking the Pulse studies
Digital health news update: A view from Barcelona and Austin
DRG Digital's semi-regular roundup of news of note in the worlds of technology, policy and pharmaceuticals (and pharma digital, and digital health, etc.)
Hallo, Siri! Voice assistants are set to take off in Europe
A quick look at how virtual assistants are faring with physicians and patients in Europe
Five things pharma marketers should know about rare disease patients
Rare disease patients face unique challenges in diagnosis and treatment. Here are five things pharma marketers should know in order to better engage this audience.
Digital health news update: The NHS' softly, softly stance on telemedicine, and Apple eats the EMR
A semi-regular look at news of note in digital health and pharma from the analyst team at DRG Digital
Pharma marketing's global woes: physician data highlights from 2017 (video)
Video highlights from Manhattan Research/DRG Digital's 2017 physician data
Digital health news update: An Apple Watch a day, and Facebook puts the screws on advertisers